CUSIP: 38870X104
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,732,241
-
Share change
-
-1,650,502
-
Total reported value
-
$431,664,766
-
Price per share
-
$12.43
-
Number of holders
-
58
-
Value change
-
-$29,347,516
-
Number of buys
-
32
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP 38870X104?
CUSIP 38870X104 identifies GRPH - GRAPHITE BIO INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 38870X104:
Institutional Holders of GRAPHITE BIO INC - COM (GRPH) as of Q4 2021
As of 31 Dec 2021,
GRAPHITE BIO INC - COM (GRPH) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,732,241 shares.
The largest 10 holders included
Samsara BioCapital, LLC, FMR LLC, RA CAPITAL MANAGEMENT, L.P., Rock Springs Capital Management LP, VR Adviser, LLC, ORBIMED ADVISORS LLC, CITADEL ADVISORS LLC, BlackRock Inc., FEDERATED HERMES, INC., and PERCEPTIVE ADVISORS LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.